Cencora, Inc. logo
Cencora, Inc. (COR)
Compare

COR Financials

SEC Filings

COR Quarterly Income Statement (USD)

Quarterly ReportTTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
06/30/2024
328.680B78.356B85.932B83.729B80.664B75.454B81.487B79.050B74.241B
Cost of Goods Sold
317.284B75.033B83.120B81.125B78.005B72.838B79.223B76.887B72.155B
11.396B3.323B2.812B2.603B2.658B2.616B2.264B2.163B2.087B
4.2%4.2%3.3%3.1%3.3%3.5%2.8%2.7%2.8%
Total Operating Expenses
7.195B1.978B1.795B1.749B1.673B1.600B1.472B1.490B1.383B
0.000.000.000.000.000.000.000.000.00
7.195B1.978B1.795B1.749B1.673B1.600B1.472B1.490B1.383B
4.201B1.345B1.016B854.599M985.520M1.016B791.776M672.865M703.371M
1.7%1.7%1.2%1.0%1.2%1.3%1.0%0.9%0.9%
3.506B2.089B708.640M-187.044M896.277M928.656M620.447M125.177M628.334M
Interest Income
101.462M13.881M20.954M31.525M35.102M28.330M33.248M33.351M27.608M
473.958M154.341M93.363M109.358M116.896M132.318M61.181M54.320M58.936M
Other Income/Expense
-695.005M743.622M-307.741M-1.042B-89.243M-87.128M-171.329M-547.688M-75.037M
2.549B1.641B559.647M-339.704M687.402M717.871M488.600M3.382M483.463M
954.113M459.044M142.514M146.027M206.528M211.239M126.728M117.711M140.740M
2.1%2.1%0.7%-0.4%0.9%1.0%0.6%0.0%0.7%
4.997B2.502B1.041B183.326M1.269B1.323B961.037M457.634M966.202M
3.2%3.2%1.2%0.2%1.6%1.8%1.2%0.6%1.3%
1.037B259.458M260.401M261.012M256.223M261.600M279.409M278.137M278.932M
13.128.442.88-1.753.553.702.520.022.44
13.048.402.87-1.753.523.682.500.022.42
194.545M194.545M194.219M193.899M193.822M193.796M193.758M198.503M198.260M
195.383M195.383M195.319M193.899M195.230M195.094M195.188M200.284M200.047M

COR Annual Income Statement (USD)

Annual Report
09/30/2025
09/30/2024
09/30/2023
09/30/2022
09/30/2021
09/30/2020
09/30/2019
09/30/2018
321.333B293.959B262.173B238.587B213.989B189.894B179.589B167.940B
Cost of Goods Sold
311.191B285.257B254.417B230.986B207.720B185.102B175.059B163.828B
10.142B8.701B7.756B7.601B6.269B4.792B4.530B4.111B
3.2%3.0%3.0%3.2%2.9%2.5%2.5%2.4%
Total Operating Expenses
6.494B5.661B5.310B4.849B3.594B2.767B2.664B2.460B
0.000.000.000.000.000.000.000.00
6.494B5.661B5.310B4.849B3.594B2.767B2.664B2.460B
3.648B3.040B2.447B2.752B2.675B2.025B1.867B1.651B
1.1%1.0%0.9%1.2%1.3%1.1%1.0%1.0%
2.258B2.004B2.161B2.183B2.222B-5.294B967.106M1.177B
Interest Income
128.205M91.691M46.719M21.309M8.470M20.639M37.705M14.941M
419.753M248.682M275.650M231.982M182.544M158.522M195.474M189.640M
Other Income/Expense
-1.389B-1.036B-285.677M-568.618M-453.152M-7.318B-899.419M-473.528M
1.554B1.509B1.745B1.699B1.540B-3.400B855.365M1.658B
690.522M484.702M428.260M516.517M677.251M-1.894B112.971M-438.469M
0.5%0.5%0.7%0.7%0.7%-1.8%0.5%1.0%
3.736B3.364B3.409B3.113B2.910B-4.734B1.651B1.867B
1.2%1.1%1.3%1.3%1.4%-2.5%0.9%1.1%
1.058B1.112B972.393M697.943M505.172M401.619M488.544M499.639M
8.027.608.628.157.48-16.604.077.61
7.967.538.538.047.39-16.604.047.53
193.820M198.503M204.591M208.472M205.919M204.783M210.165M217.872M
195.214M200.284M204.591M211.210M208.465M204.783M211.840M220.336M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Cencora, Inc.

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Conshohocken, PA
47,000 employees
Healthcare / Medical - Distribution
Sector
Healthcare
Industry
Medical - Distribution
CEO
Robert Mauch